| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 146 | 2025 | 8717 | 6.500 |
Why?
|
| Cognition Disorders | 55 | 2019 | 3967 | 2.370 |
Why?
|
| Neurodegenerative Diseases | 21 | 2024 | 1089 | 2.130 |
Why?
|
| Schizophrenia | 61 | 2017 | 6976 | 2.020 |
Why?
|
| Dementia | 38 | 2024 | 2741 | 2.000 |
Why?
|
| Brain | 87 | 2024 | 27159 | 1.870 |
Why?
|
| tau Proteins | 39 | 2024 | 2107 | 1.820 |
Why?
|
| Prion Diseases | 4 | 2024 | 99 | 1.800 |
Why?
|
| Neurofibrillary Tangles | 23 | 2017 | 457 | 1.730 |
Why?
|
| Aging | 34 | 2023 | 8731 | 1.710 |
Why?
|
| Plaque, Amyloid | 19 | 2017 | 769 | 1.320 |
Why?
|
| Synapses | 9 | 2021 | 1759 | 1.300 |
Why?
|
| Olfactory Mucosa | 8 | 2013 | 101 | 1.280 |
Why?
|
| Amyloid beta-Peptides | 34 | 2024 | 3887 | 1.230 |
Why?
|
| Neuropsychological Tests | 55 | 2024 | 7119 | 1.200 |
Why?
|
| Insulin Resistance | 8 | 2024 | 3989 | 1.170 |
Why?
|
| Cognition | 26 | 2024 | 7057 | 1.160 |
Why?
|
| Aged, 80 and over | 145 | 2024 | 59550 | 1.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 2024 | 558 | 1.070 |
Why?
|
| Memory Disorders | 8 | 2020 | 1193 | 1.070 |
Why?
|
| Tauopathies | 11 | 2024 | 325 | 1.030 |
Why?
|
| Aged | 216 | 2024 | 171343 | 0.990 |
Why?
|
| Insulin | 13 | 2024 | 6608 | 0.990 |
Why?
|
| Positron-Emission Tomography | 22 | 2024 | 6550 | 0.950 |
Why?
|
| Apolipoproteins E | 13 | 2022 | 1459 | 0.900 |
Why?
|
| Hippocampus | 23 | 2015 | 3776 | 0.800 |
Why?
|
| Hydrocephalus, Normal Pressure | 5 | 2024 | 101 | 0.800 |
Why?
|
| Cerebrovascular Disorders | 4 | 2021 | 1479 | 0.790 |
Why?
|
| Apolipoprotein E4 | 12 | 2020 | 709 | 0.780 |
Why?
|
| Male | 254 | 2024 | 364142 | 0.750 |
Why?
|
| Olfaction Disorders | 13 | 2017 | 225 | 0.750 |
Why?
|
| Frontotemporal Lobar Degeneration | 8 | 2014 | 102 | 0.730 |
Why?
|
| Ethylene Glycols | 3 | 2018 | 196 | 0.720 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 481 | 0.720 |
Why?
|
| Coal Mining | 1 | 2020 | 12 | 0.720 |
Why?
|
| Humans | 345 | 2025 | 766766 | 0.710 |
Why?
|
| Lewy Bodies | 8 | 2018 | 140 | 0.700 |
Why?
|
| Nerve Tissue Proteins | 14 | 2015 | 4400 | 0.680 |
Why?
|
| Female | 246 | 2024 | 396520 | 0.670 |
Why?
|
| Olfactory Bulb | 6 | 2015 | 198 | 0.660 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2010 | 1071 | 0.660 |
Why?
|
| Autopsy | 15 | 2021 | 1011 | 0.650 |
Why?
|
| Fluorine Radioisotopes | 6 | 2018 | 405 | 0.650 |
Why?
|
| Delirium | 9 | 2024 | 1698 | 0.630 |
Why?
|
| Neurons | 27 | 2016 | 9515 | 0.620 |
Why?
|
| Dendrites | 3 | 2014 | 471 | 0.620 |
Why?
|
| Aniline Compounds | 5 | 2018 | 1079 | 0.620 |
Why?
|
| Disease Progression | 25 | 2024 | 13640 | 0.610 |
Why?
|
| Hypoglycemic Agents | 5 | 2024 | 3108 | 0.590 |
Why?
|
| Clinical Chemistry Tests | 1 | 2018 | 59 | 0.590 |
Why?
|
| Carrier Proteins | 9 | 2011 | 4924 | 0.570 |
Why?
|
| Parahippocampal Gyrus | 3 | 2003 | 117 | 0.560 |
Why?
|
| Life Style | 4 | 2024 | 3926 | 0.540 |
Why?
|
| Amyloid | 4 | 2022 | 849 | 0.540 |
Why?
|
| Methylphenidate | 1 | 2020 | 480 | 0.530 |
Why?
|
| Cerebral Cortex | 14 | 2024 | 5753 | 0.530 |
Why?
|
| Hyperinsulinism | 1 | 2019 | 402 | 0.520 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2014 | 903 | 0.510 |
Why?
|
| Temporal Lobe | 20 | 2021 | 1716 | 0.510 |
Why?
|
| Memory, Short-Term | 4 | 2019 | 1004 | 0.500 |
Why?
|
| Glial Fibrillary Acidic Protein | 6 | 2024 | 564 | 0.500 |
Why?
|
| Immunohistochemistry | 30 | 2015 | 11061 | 0.490 |
Why?
|
| Olfactory Receptor Neurons | 3 | 2008 | 95 | 0.490 |
Why?
|
| alpha-Synuclein | 9 | 2024 | 771 | 0.480 |
Why?
|
| Fluorodeoxyglucose F18 | 17 | 2024 | 2028 | 0.470 |
Why?
|
| Schizophrenic Psychology | 17 | 2016 | 1647 | 0.470 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1319 | 0.470 |
Why?
|
| Geriatric Psychiatry | 2 | 2005 | 70 | 0.460 |
Why?
|
| Middle Aged | 122 | 2024 | 223257 | 0.460 |
Why?
|
| Metformin | 2 | 2024 | 908 | 0.450 |
Why?
|
| Case-Control Studies | 34 | 2021 | 22248 | 0.450 |
Why?
|
| Magnetic Resonance Imaging | 46 | 2023 | 36567 | 0.440 |
Why?
|
| Neurofilament Proteins | 5 | 2024 | 335 | 0.440 |
Why?
|
| Psychiatric Status Rating Scales | 26 | 2017 | 6020 | 0.440 |
Why?
|
| Benzothiazoles | 4 | 2015 | 244 | 0.420 |
Why?
|
| Longitudinal Studies | 32 | 2024 | 14762 | 0.410 |
Why?
|
| Serine | 3 | 2023 | 828 | 0.410 |
Why?
|
| Post-Synaptic Density | 2 | 2014 | 11 | 0.410 |
Why?
|
| Depressive Disorder | 5 | 2019 | 3715 | 0.400 |
Why?
|
| AIDS Dementia Complex | 2 | 2003 | 154 | 0.390 |
Why?
|
| Cognitive Reserve | 1 | 2012 | 92 | 0.390 |
Why?
|
| Drug Repositioning | 1 | 2014 | 246 | 0.390 |
Why?
|
| Depression | 10 | 2015 | 8228 | 0.390 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2012 | 138 | 0.380 |
Why?
|
| C-Reactive Protein | 4 | 2020 | 3853 | 0.380 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2012 | 102 | 0.360 |
Why?
|
| Phosphorylation | 14 | 2024 | 8307 | 0.360 |
Why?
|
| Peptide Fragments | 13 | 2023 | 5143 | 0.360 |
Why?
|
| Cerebral Infarction | 5 | 2017 | 968 | 0.350 |
Why?
|
| Prefrontal Cortex | 12 | 2024 | 2224 | 0.350 |
Why?
|
| Catholicism | 1 | 2010 | 32 | 0.350 |
Why?
|
| DNA-Binding Proteins | 13 | 2024 | 9611 | 0.350 |
Why?
|
| Corticosterone | 1 | 2011 | 301 | 0.350 |
Why?
|
| Executive Function | 4 | 2015 | 1396 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 12245 | 0.340 |
Why?
|
| Alanine | 1 | 2013 | 613 | 0.340 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2010 | 54 | 0.340 |
Why?
|
| Dystrophin-Associated Proteins | 6 | 2011 | 60 | 0.340 |
Why?
|
| Brain Chemistry | 8 | 2019 | 951 | 0.340 |
Why?
|
| Proteomics | 4 | 2024 | 3914 | 0.330 |
Why?
|
| Electron Transport | 1 | 2010 | 211 | 0.320 |
Why?
|
| Glycine | 1 | 2013 | 670 | 0.320 |
Why?
|
| Thiazoles | 4 | 2015 | 1529 | 0.320 |
Why?
|
| Analysis of Variance | 12 | 2017 | 6214 | 0.320 |
Why?
|
| Prions | 2 | 2022 | 177 | 0.310 |
Why?
|
| Presenilin-1 | 1 | 2013 | 665 | 0.310 |
Why?
|
| Neuronal Plasticity | 6 | 2015 | 1446 | 0.310 |
Why?
|
| Age of Onset | 16 | 2014 | 3342 | 0.300 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2009 | 113 | 0.300 |
Why?
|
| Religion and Psychology | 1 | 2010 | 180 | 0.300 |
Why?
|
| Olfactory Pathways | 4 | 2003 | 131 | 0.300 |
Why?
|
| Limbic System | 7 | 2015 | 418 | 0.290 |
Why?
|
| Genotype | 25 | 2022 | 13036 | 0.290 |
Why?
|
| Clinical Trials as Topic | 4 | 2025 | 8045 | 0.290 |
Why?
|
| Radiopharmaceuticals | 10 | 2021 | 2704 | 0.280 |
Why?
|
| Pick Disease of the Brain | 3 | 2018 | 42 | 0.280 |
Why?
|
| Inclusion Bodies | 7 | 2018 | 277 | 0.280 |
Why?
|
| Estrogens | 2 | 2010 | 1528 | 0.280 |
Why?
|
| TDP-43 Proteinopathies | 3 | 2018 | 40 | 0.280 |
Why?
|
| Signal Transduction | 10 | 2024 | 23619 | 0.280 |
Why?
|
| Smell | 7 | 2017 | 259 | 0.280 |
Why?
|
| Microfilament Proteins | 2 | 2015 | 1129 | 0.270 |
Why?
|
| Motor Activity | 2 | 2014 | 2711 | 0.270 |
Why?
|
| Lewy Body Disease | 4 | 2018 | 252 | 0.270 |
Why?
|
| Stress, Psychological | 6 | 2015 | 4527 | 0.270 |
Why?
|
| Gene Frequency | 9 | 2017 | 3624 | 0.270 |
Why?
|
| Tomography, Emission-Computed | 14 | 2004 | 1006 | 0.260 |
Why?
|
| Chromatography, Liquid | 4 | 2021 | 996 | 0.260 |
Why?
|
| Caspase 3 | 1 | 2008 | 730 | 0.260 |
Why?
|
| Epilepsy, Temporal Lobe | 6 | 2001 | 390 | 0.260 |
Why?
|
| Dentate Gyrus | 2 | 2005 | 165 | 0.250 |
Why?
|
| Neuregulin-1 | 1 | 2006 | 136 | 0.250 |
Why?
|
| Parkinson Disease | 8 | 2015 | 2884 | 0.250 |
Why?
|
| Frontotemporal Dementia | 3 | 2014 | 249 | 0.240 |
Why?
|
| Adult | 84 | 2024 | 223307 | 0.240 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4554 | 0.240 |
Why?
|
| Synaptic Vesicles | 1 | 2006 | 187 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 10384 | 0.240 |
Why?
|
| Gene Expression | 8 | 2012 | 7585 | 0.240 |
Why?
|
| Cytoskeletal Proteins | 4 | 2011 | 1325 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2023 | 8926 | 0.230 |
Why?
|
| Cohort Studies | 31 | 2023 | 41710 | 0.230 |
Why?
|
| Neuropil Threads | 2 | 2000 | 3 | 0.230 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2022 | 50 | 0.230 |
Why?
|
| Biological Specimen Banks | 2 | 2024 | 787 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 1935 | 0.230 |
Why?
|
| Nerve Degeneration | 5 | 2012 | 748 | 0.230 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2024 | 1481 | 0.230 |
Why?
|
| Receptors, Glutamate | 2 | 2004 | 228 | 0.230 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 229 | 0.230 |
Why?
|
| Research Design | 3 | 2021 | 6207 | 0.230 |
Why?
|
| Myelin Proteins | 2 | 2015 | 212 | 0.230 |
Why?
|
| Locus Coeruleus | 2 | 2024 | 241 | 0.220 |
Why?
|
| Wheelchairs | 1 | 2024 | 78 | 0.220 |
Why?
|
| Vesicular Transport Proteins | 1 | 2006 | 376 | 0.220 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 956 | 0.220 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 5887 | 0.220 |
Why?
|
| Nervous System | 2 | 2005 | 542 | 0.210 |
Why?
|
| Linear Models | 11 | 2015 | 5874 | 0.210 |
Why?
|
| Rectum | 2 | 2019 | 896 | 0.210 |
Why?
|
| Immunologic Tests | 1 | 2024 | 101 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2017 | 16044 | 0.210 |
Why?
|
| Atrophy | 7 | 2014 | 1631 | 0.210 |
Why?
|
| Amyloidogenic Proteins | 1 | 2024 | 151 | 0.210 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 242 | 0.210 |
Why?
|
| Entorhinal Cortex | 4 | 2003 | 285 | 0.210 |
Why?
|
| Cryoprotective Agents | 1 | 2024 | 123 | 0.210 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2024 | 250 | 0.210 |
Why?
|
| Severity of Illness Index | 22 | 2017 | 15908 | 0.210 |
Why?
|
| Age Factors | 16 | 2020 | 18397 | 0.200 |
Why?
|
| Parietal Lobe | 4 | 2021 | 859 | 0.200 |
Why?
|
| Neurogranin | 1 | 2022 | 15 | 0.200 |
Why?
|
| Inositol | 1 | 2003 | 215 | 0.200 |
Why?
|
| Reference Values | 9 | 2018 | 4913 | 0.200 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2744 | 0.200 |
Why?
|
| Glucose | 12 | 2023 | 4340 | 0.200 |
Why?
|
| Spinal Cord | 2 | 2010 | 1811 | 0.200 |
Why?
|
| Reproducibility of Results | 15 | 2024 | 20144 | 0.200 |
Why?
|
| Pseudopodia | 1 | 2022 | 168 | 0.200 |
Why?
|
| Exercise | 3 | 2017 | 5945 | 0.200 |
Why?
|
| Pressure | 2 | 2024 | 1172 | 0.200 |
Why?
|
| Behavioral Symptoms | 2 | 2016 | 188 | 0.200 |
Why?
|
| Memory | 7 | 2013 | 2192 | 0.200 |
Why?
|
| Epilepsies, Partial | 4 | 2001 | 431 | 0.190 |
Why?
|
| Choline | 1 | 2003 | 511 | 0.190 |
Why?
|
| Synaptosomes | 3 | 2011 | 116 | 0.190 |
Why?
|
| Philadelphia | 2 | 2013 | 270 | 0.190 |
Why?
|
| Diagnosis, Differential | 15 | 2020 | 12985 | 0.190 |
Why?
|
| Cross-Over Studies | 2 | 2018 | 2108 | 0.190 |
Why?
|
| Educational Status | 8 | 2017 | 2510 | 0.190 |
Why?
|
| Creatine | 1 | 2003 | 424 | 0.190 |
Why?
|
| Diabetes Complications | 3 | 2021 | 1319 | 0.180 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 606 | 0.180 |
Why?
|
| Drug Discovery | 3 | 2025 | 1065 | 0.180 |
Why?
|
| Nervous System Diseases | 3 | 2024 | 1659 | 0.180 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1865 | 0.180 |
Why?
|
| Appalachian Region | 1 | 2020 | 5 | 0.180 |
Why?
|
| Cytoskeleton | 2 | 1996 | 1179 | 0.180 |
Why?
|
| Supranuclear Palsy, Progressive | 3 | 2018 | 82 | 0.180 |
Why?
|
| Glycolysis | 2 | 2023 | 838 | 0.180 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2000 | 23 | 0.180 |
Why?
|
| Cell Count | 7 | 2013 | 1826 | 0.180 |
Why?
|
| Animals | 36 | 2023 | 168930 | 0.170 |
Why?
|
| Metabolomics | 3 | 2022 | 1675 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 15657 | 0.170 |
Why?
|
| Amino Acids | 2 | 2024 | 1711 | 0.170 |
Why?
|
| Mutation | 6 | 2014 | 30213 | 0.170 |
Why?
|
| Risk Factors | 32 | 2020 | 74881 | 0.170 |
Why?
|
| Spin Labels | 2 | 2012 | 334 | 0.170 |
Why?
|
| Postoperative Complications | 8 | 2022 | 15831 | 0.170 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2020 | 103 | 0.170 |
Why?
|
| Receptors, GABA | 1 | 2021 | 312 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 22352 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1331 | 0.170 |
Why?
|
| Single-Blind Method | 2 | 2024 | 1587 | 0.170 |
Why?
|
| Brain Mapping | 11 | 2019 | 6596 | 0.170 |
Why?
|
| Renin-Angiotensin System | 1 | 2024 | 737 | 0.160 |
Why?
|
| Mice | 20 | 2023 | 81889 | 0.160 |
Why?
|
| Pilot Projects | 4 | 2022 | 8728 | 0.160 |
Why?
|
| Frontal Lobe | 11 | 2007 | 1408 | 0.160 |
Why?
|
| Subcellular Fractions | 2 | 2011 | 526 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 28 | 0.160 |
Why?
|
| Membrane Proteins | 5 | 2015 | 7868 | 0.160 |
Why?
|
| Gliosis | 2 | 2000 | 246 | 0.160 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 26310 | 0.160 |
Why?
|
| Statistics as Topic | 5 | 2016 | 2351 | 0.150 |
Why?
|
| Antipsychotic Agents | 11 | 2015 | 3078 | 0.150 |
Why?
|
| Neocortex | 2 | 2013 | 414 | 0.150 |
Why?
|
| Prospective Studies | 24 | 2023 | 54871 | 0.150 |
Why?
|
| Intermediate Filaments | 3 | 2020 | 171 | 0.150 |
Why?
|
| Caudate Nucleus | 1 | 2000 | 388 | 0.150 |
Why?
|
| Heterozygote | 2 | 2024 | 2795 | 0.150 |
Why?
|
| Blood-Brain Barrier | 3 | 2021 | 1028 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2019 | 18075 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2024 | 3511 | 0.150 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1999 | 92 | 0.150 |
Why?
|
| Motor Cortex | 3 | 2021 | 1004 | 0.150 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 7609 | 0.150 |
Why?
|
| Astrocytes | 3 | 2010 | 1351 | 0.150 |
Why?
|
| Neurites | 3 | 2000 | 389 | 0.150 |
Why?
|
| Interneurons | 1 | 2003 | 592 | 0.150 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2020 | 228 | 0.150 |
Why?
|
| Neural Pathways | 8 | 2005 | 3079 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2014 | 1657 | 0.150 |
Why?
|
| Mental Status Schedule | 6 | 2017 | 315 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 353 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2001 | 0.140 |
Why?
|
| Mass Spectrometry | 2 | 2023 | 2198 | 0.140 |
Why?
|
| Anastomotic Leak | 1 | 2019 | 170 | 0.140 |
Why?
|
| Genetic Loci | 2 | 2019 | 2630 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2013 | 4047 | 0.140 |
Why?
|
| PC12 Cells | 2 | 2016 | 317 | 0.140 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1514 | 0.140 |
Why?
|
| Neuroglia | 1 | 2003 | 960 | 0.140 |
Why?
|
| Neuropeptides | 1 | 2023 | 950 | 0.140 |
Why?
|
| Adipokines | 1 | 2019 | 308 | 0.140 |
Why?
|
| Geriatric Assessment | 6 | 2017 | 1422 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 130 | 0.140 |
Why?
|
| Olfactory Marker Protein | 3 | 2013 | 12 | 0.140 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1997 | 110 | 0.140 |
Why?
|
| Mental Disorders | 3 | 2023 | 6869 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2022 | 3681 | 0.140 |
Why?
|
| Thalamus | 3 | 2000 | 1040 | 0.140 |
Why?
|
| Mice, Inbred DBA | 2 | 2009 | 624 | 0.140 |
Why?
|
| Exploratory Behavior | 2 | 2009 | 271 | 0.140 |
Why?
|
| Independent Living | 1 | 2021 | 584 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 5 | 2023 | 9244 | 0.140 |
Why?
|
| Purkinje Cells | 1 | 1998 | 228 | 0.140 |
Why?
|
| Haplotypes | 4 | 2019 | 2727 | 0.140 |
Why?
|
| Receptors, Nerve Growth Factor | 3 | 2005 | 199 | 0.130 |
Why?
|
| Mitochondria | 1 | 2010 | 3677 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 386 | 0.130 |
Why?
|
| Calcium Channels | 2 | 1997 | 622 | 0.130 |
Why?
|
| Amnesia | 2 | 2015 | 257 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 13485 | 0.130 |
Why?
|
| Myelin Sheath | 2 | 2001 | 650 | 0.130 |
Why?
|
| Loneliness | 2 | 2010 | 211 | 0.130 |
Why?
|
| Serotonin | 1 | 2021 | 1045 | 0.130 |
Why?
|
| Residence Characteristics | 2 | 2020 | 2116 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 740 | 0.130 |
Why?
|
| Inflammation | 5 | 2022 | 10860 | 0.130 |
Why?
|
| Alleles | 11 | 2020 | 6895 | 0.130 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 624 | 0.130 |
Why?
|
| Behavior Control | 1 | 2016 | 46 | 0.130 |
Why?
|
| Protein Isoforms | 3 | 2011 | 1716 | 0.130 |
Why?
|
| Behavior Therapy | 2 | 2024 | 886 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2023 | 1147 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 1997 | 857 | 0.130 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 135 | 0.120 |
Why?
|
| Neuroblastoma | 2 | 2022 | 1266 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2019 | 584 | 0.120 |
Why?
|
| Plasma | 2 | 2022 | 583 | 0.120 |
Why?
|
| Social Behavior | 3 | 2013 | 1147 | 0.120 |
Why?
|
| SOS1 Protein | 1 | 2015 | 40 | 0.120 |
Why?
|
| Sensation | 1 | 2017 | 331 | 0.120 |
Why?
|
| Sensitivity and Specificity | 16 | 2019 | 14652 | 0.120 |
Why?
|
| Orthopedic Procedures | 2 | 2022 | 1279 | 0.120 |
Why?
|
| Cerebellum | 4 | 1998 | 1520 | 0.120 |
Why?
|
| Sex Factors | 9 | 2020 | 10619 | 0.120 |
Why?
|
| Rhizotomy | 1 | 1995 | 30 | 0.120 |
Why?
|
| Endopeptidases | 1 | 1999 | 762 | 0.120 |
Why?
|
| Area Under Curve | 3 | 2015 | 1638 | 0.120 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2015 | 42 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2012 | 1428 | 0.120 |
Why?
|
| Basal Ganglia | 6 | 2012 | 549 | 0.120 |
Why?
|
| Basal Ganglia Diseases | 1 | 2015 | 145 | 0.120 |
Why?
|
| Drug Therapy, Combination | 2 | 2025 | 6307 | 0.120 |
Why?
|
| Comorbidity | 10 | 2020 | 10580 | 0.120 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2015 | 37 | 0.120 |
Why?
|
| Allostasis | 1 | 2015 | 76 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7431 | 0.120 |
Why?
|
| Aggression | 2 | 2003 | 748 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2018 | 3684 | 0.120 |
Why?
|
| Visual Perception | 2 | 2017 | 1392 | 0.120 |
Why?
|
| Organ Size | 3 | 2012 | 2261 | 0.120 |
Why?
|
| Follow-Up Studies | 14 | 2019 | 39309 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3139 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 7 | 2012 | 2672 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2011 | 5022 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 2902 | 0.110 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2013 | 41 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2024 | 2465 | 0.110 |
Why?
|
| Substantia Nigra | 2 | 2013 | 346 | 0.110 |
Why?
|
| Activities of Daily Living | 5 | 2010 | 2429 | 0.110 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2662 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2017 | 993 | 0.110 |
Why?
|
| DNA, Complementary | 1 | 1997 | 1989 | 0.110 |
Why?
|
| Association Learning | 1 | 2015 | 219 | 0.110 |
Why?
|
| Fragile X Syndrome | 1 | 2015 | 116 | 0.110 |
Why?
|
| Dominance, Cerebral | 4 | 2003 | 616 | 0.110 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1418 | 0.110 |
Why?
|
| Cytosol | 2 | 2024 | 887 | 0.110 |
Why?
|
| Pain Measurement | 1 | 2024 | 3576 | 0.110 |
Why?
|
| COS Cells | 2 | 2006 | 1135 | 0.110 |
Why?
|
| Image Enhancement | 2 | 2003 | 2857 | 0.110 |
Why?
|
| Psychometrics | 4 | 2016 | 3060 | 0.110 |
Why?
|
| Psychomotor Agitation | 1 | 2016 | 307 | 0.110 |
Why?
|
| Personality | 2 | 2007 | 560 | 0.110 |
Why?
|
| Automation | 1 | 2015 | 586 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2021 | 2867 | 0.100 |
Why?
|
| Psychotropic Drugs | 2 | 2016 | 880 | 0.100 |
Why?
|
| Homes for the Aged | 1 | 2015 | 273 | 0.100 |
Why?
|
| Immunity | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Regression Analysis | 6 | 2013 | 6329 | 0.100 |
Why?
|
| Pandemics | 3 | 2023 | 8735 | 0.100 |
Why?
|
| Circle of Willis | 1 | 2012 | 77 | 0.100 |
Why?
|
| Leisure Activities | 1 | 2014 | 310 | 0.100 |
Why?
|
| Genetic Variation | 4 | 2014 | 6612 | 0.100 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 355 | 0.100 |
Why?
|
| Urinary Catheterization | 1 | 1993 | 195 | 0.100 |
Why?
|
| Apolipoprotein E2 | 1 | 2013 | 134 | 0.100 |
Why?
|
| Administration, Intranasal | 1 | 2014 | 482 | 0.100 |
Why?
|
| Genome-Wide Association Study | 8 | 2019 | 12806 | 0.100 |
Why?
|
| Microglia | 2 | 2017 | 1370 | 0.100 |
Why?
|
| Attention | 6 | 2015 | 2413 | 0.100 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3432 | 0.100 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 128 | 0.100 |
Why?
|
| Stem Cells | 1 | 2005 | 3537 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2014 | 539 | 0.100 |
Why?
|
| Apathy | 1 | 2013 | 107 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 3692 | 0.100 |
Why?
|
| Venoms | 1 | 2012 | 94 | 0.100 |
Why?
|
| Phosphoserine | 1 | 2012 | 204 | 0.100 |
Why?
|
| Puerto Rico | 1 | 2013 | 380 | 0.090 |
Why?
|
| Mesencephalon | 1 | 2013 | 337 | 0.090 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2012 | 59 | 0.090 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2024 | 65273 | 0.090 |
Why?
|
| Psychiatry | 1 | 2023 | 1715 | 0.090 |
Why?
|
| Cerebellar Cortex | 1 | 2012 | 108 | 0.090 |
Why?
|
| Urethra | 1 | 1993 | 406 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2013 | 2274 | 0.090 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 205 | 0.090 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1991 | 143 | 0.090 |
Why?
|
| Adolescent | 25 | 2024 | 88904 | 0.090 |
Why?
|
| Maze Learning | 2 | 2012 | 479 | 0.090 |
Why?
|
| Mice, Transgenic | 4 | 2023 | 9547 | 0.090 |
Why?
|
| Caribbean Region | 1 | 2011 | 193 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 5536 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2184 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2019 | 3804 | 0.090 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 399 | 0.090 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2010 | 23 | 0.090 |
Why?
|
| Pennsylvania | 3 | 2013 | 615 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 268 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 684 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2013 | 806 | 0.090 |
Why?
|
| Motor Skills Disorders | 1 | 2010 | 89 | 0.090 |
Why?
|
| Interpersonal Relations | 4 | 2010 | 1432 | 0.090 |
Why?
|
| Consensus | 3 | 2021 | 3208 | 0.090 |
Why?
|
| Antibody Affinity | 1 | 2011 | 251 | 0.090 |
Why?
|
| Cues | 1 | 2015 | 877 | 0.090 |
Why?
|
| Cells, Cultured | 5 | 2024 | 18984 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2012 | 2519 | 0.080 |
Why?
|
| Odds Ratio | 4 | 2017 | 9661 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2005 | 11651 | 0.080 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 151 | 0.080 |
Why?
|
| Motor Skills | 1 | 2013 | 519 | 0.080 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 281 | 0.080 |
Why?
|
| Psychomotor Performance | 3 | 2020 | 1885 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2010 | 3459 | 0.080 |
Why?
|
| Clergy | 3 | 2008 | 79 | 0.080 |
Why?
|
| Linkage Disequilibrium | 3 | 2017 | 1996 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5306 | 0.080 |
Why?
|
| Calcium | 1 | 2022 | 5783 | 0.080 |
Why?
|
| Systems Integration | 1 | 2011 | 425 | 0.080 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 88 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2015 | 1117 | 0.080 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2010 | 197 | 0.080 |
Why?
|
| Language Disorders | 2 | 2001 | 140 | 0.080 |
Why?
|
| Chromogranin A | 2 | 2023 | 47 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2011 | 494 | 0.080 |
Why?
|
| Cell Movement | 4 | 2022 | 5199 | 0.080 |
Why?
|
| Oxygen | 2 | 2019 | 4251 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 3702 | 0.080 |
Why?
|
| Sensory Thresholds | 7 | 2006 | 377 | 0.080 |
Why?
|
| Neoplasms | 2 | 2017 | 22350 | 0.080 |
Why?
|
| Dogs | 2 | 1993 | 3834 | 0.080 |
Why?
|
| Macaca fascicularis | 2 | 2012 | 908 | 0.080 |
Why?
|
| Lysine | 1 | 2013 | 997 | 0.080 |
Why?
|
| Pain | 1 | 2024 | 5098 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2012 | 636 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1313 | 0.080 |
Why?
|
| Tissue Extracts | 1 | 2008 | 139 | 0.080 |
Why?
|
| Dendritic Spines | 1 | 2010 | 244 | 0.080 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1183 | 0.080 |
Why?
|
| Functional Laterality | 7 | 2007 | 2243 | 0.080 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2011 | 529 | 0.080 |
Why?
|
| GAP-43 Protein | 2 | 2013 | 152 | 0.070 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 494 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2009 | 240 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 697 | 0.070 |
Why?
|
| Lipids | 1 | 2019 | 3319 | 0.070 |
Why?
|
| Parkinsonian Disorders | 2 | 2008 | 285 | 0.070 |
Why?
|
| Mental Recall | 2 | 2013 | 1218 | 0.070 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 4810 | 0.070 |
Why?
|
| Rats | 6 | 2016 | 23717 | 0.070 |
Why?
|
| Nursing Homes | 1 | 2015 | 1084 | 0.070 |
Why?
|
| Statistics, Nonparametric | 3 | 2010 | 2846 | 0.070 |
Why?
|
| Mice, Inbred C3H | 2 | 2006 | 915 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 1 | 2008 | 165 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2012 | 1964 | 0.070 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 18330 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2020 | 20708 | 0.070 |
Why?
|
| Electroencephalography | 9 | 2023 | 6282 | 0.070 |
Why?
|
| Optics and Photonics | 1 | 2008 | 305 | 0.070 |
Why?
|
| Agnosia | 1 | 2007 | 67 | 0.070 |
Why?
|
| Microcirculation | 1 | 2012 | 1282 | 0.070 |
Why?
|
| Synaptophysin | 2 | 2015 | 138 | 0.070 |
Why?
|
| Biogenic Monoamines | 1 | 2006 | 50 | 0.070 |
Why?
|
| Virion | 1 | 2008 | 428 | 0.070 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2006 | 33 | 0.070 |
Why?
|
| Biopsy | 3 | 2013 | 6779 | 0.070 |
Why?
|
| Social Support | 3 | 2017 | 2191 | 0.060 |
Why?
|
| Demography | 1 | 2011 | 1641 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2013 | 1345 | 0.060 |
Why?
|
| Antibodies | 2 | 2004 | 2421 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2012 | 1592 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 1991 | 649 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 2662 | 0.060 |
Why?
|
| Echoencephalography | 1 | 2006 | 134 | 0.060 |
Why?
|
| Language | 3 | 2013 | 1550 | 0.060 |
Why?
|
| Psychosurgery | 2 | 1999 | 86 | 0.060 |
Why?
|
| HIV-1 | 1 | 2003 | 6948 | 0.060 |
Why?
|
| Overweight | 1 | 2017 | 2446 | 0.060 |
Why?
|
| Incidence | 9 | 2020 | 21525 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2024 | 2456 | 0.060 |
Why?
|
| Cadaver | 2 | 2009 | 1362 | 0.060 |
Why?
|
| Retrospective Studies | 13 | 2019 | 81635 | 0.060 |
Why?
|
| Anal Canal | 2 | 2019 | 375 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 1077 | 0.060 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2005 | 48 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2014 | 1389 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 1996 | 420 | 0.060 |
Why?
|
| Time Factors | 7 | 2018 | 40149 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 334 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2008 | 455 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3077 | 0.060 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2012 | 887 | 0.060 |
Why?
|
| Retinoid X Receptors | 1 | 2005 | 91 | 0.060 |
Why?
|
| Neuronavigation | 1 | 2006 | 169 | 0.060 |
Why?
|
| Double-Blind Method | 4 | 2024 | 12430 | 0.060 |
Why?
|
| Databases, Factual | 4 | 2015 | 8066 | 0.060 |
Why?
|
| Health Services Research | 1 | 2012 | 1811 | 0.060 |
Why?
|
| Cell Size | 2 | 1998 | 625 | 0.060 |
Why?
|
| Synapsins | 2 | 2015 | 43 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2005 | 310 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6422 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4570 | 0.060 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 15416 | 0.060 |
Why?
|
| Lasers | 1 | 2008 | 951 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 3 | 2004 | 261 | 0.060 |
Why?
|
| Evoked Potentials, Visual | 1 | 2007 | 417 | 0.060 |
Why?
|
| Postural Balance | 1 | 2009 | 637 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 980 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 6222 | 0.060 |
Why?
|
| Software | 2 | 2015 | 4466 | 0.060 |
Why?
|
| Sex Ratio | 1 | 2004 | 107 | 0.060 |
Why?
|
| Cell Shape | 1 | 2005 | 372 | 0.060 |
Why?
|
| Prevalence | 6 | 2019 | 15835 | 0.050 |
Why?
|
| Deoxyguanosine | 1 | 2004 | 96 | 0.050 |
Why?
|
| Leptin | 2 | 2024 | 1596 | 0.050 |
Why?
|
| ROC Curve | 3 | 2017 | 3620 | 0.050 |
Why?
|
| Synucleins | 2 | 2000 | 108 | 0.050 |
Why?
|
| Cholesterol | 2 | 2022 | 2903 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2008 | 751 | 0.050 |
Why?
|
| Logistic Models | 4 | 2013 | 13278 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2023 | 88 | 0.050 |
Why?
|
| MELAS Syndrome | 1 | 2003 | 55 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2008 | 3788 | 0.050 |
Why?
|
| rab3A GTP-Binding Protein | 1 | 2002 | 5 | 0.050 |
Why?
|
| Time Perception | 1 | 2003 | 87 | 0.050 |
Why?
|
| Observer Variation | 5 | 2010 | 2614 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 12064 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 2783 | 0.050 |
Why?
|
| Epilepsy | 4 | 2001 | 3317 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2000 | 2510 | 0.050 |
Why?
|
| Protein Transport | 1 | 2008 | 1942 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1110 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2006 | 1175 | 0.050 |
Why?
|
| Peptides | 2 | 2012 | 4344 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3587 | 0.050 |
Why?
|
| Clusterin | 1 | 2022 | 72 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 5 | 2012 | 1143 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Chromogranins | 1 | 2023 | 160 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6507 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
| Entropy | 1 | 2023 | 210 | 0.050 |
Why?
|
| Autoradiography | 2 | 2000 | 725 | 0.050 |
Why?
|
| Chronic Disease | 5 | 2007 | 9357 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 921 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 299 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2251 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2004 | 630 | 0.050 |
Why?
|
| Brain Injuries | 1 | 1993 | 2053 | 0.050 |
Why?
|
| Proteome | 2 | 2022 | 1894 | 0.050 |
Why?
|
| Cytokinesis | 1 | 2022 | 170 | 0.050 |
Why?
|
| Confusion | 1 | 2003 | 278 | 0.050 |
Why?
|
| Personality Disorders | 1 | 2006 | 727 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2022 | 305 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 2003 | 1697 | 0.050 |
Why?
|
| Chicago | 2 | 2013 | 255 | 0.050 |
Why?
|
| Ganglioneuroma | 1 | 2001 | 53 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 820 | 0.050 |
Why?
|
| Chemical Fractionation | 1 | 2000 | 60 | 0.050 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2000 | 22 | 0.050 |
Why?
|
| Evoked Potentials | 1 | 2007 | 1050 | 0.040 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2000 | 35 | 0.040 |
Why?
|
| Child Language | 1 | 2001 | 62 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2006 | 1021 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2005 | 1882 | 0.040 |
Why?
|
| Flumazenil | 1 | 2000 | 84 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2025 | 797 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2011 | 4032 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 1997 | 89 | 0.040 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2000 | 94 | 0.040 |
Why?
|
| Arthrography | 1 | 2001 | 149 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2004 | 573 | 0.040 |
Why?
|
| Cell Death | 2 | 2003 | 1676 | 0.040 |
Why?
|
| Multiple System Atrophy | 2 | 2018 | 132 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2023 | 381 | 0.040 |
Why?
|
| Transcription Factor TFIID | 1 | 2020 | 150 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 196 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 610 | 0.040 |
Why?
|
| Health Policy | 1 | 2012 | 2698 | 0.040 |
Why?
|
| Battered Women | 1 | 2000 | 36 | 0.040 |
Why?
|
| Acetylation | 2 | 2013 | 1054 | 0.040 |
Why?
|
| Aprotinin | 1 | 2000 | 94 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 2006 | 947 | 0.040 |
Why?
|
| Models, Neurological | 3 | 2007 | 1747 | 0.040 |
Why?
|
| Health Status | 1 | 2013 | 4087 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2008 | 2870 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2001 | 329 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2019 | 119 | 0.040 |
Why?
|
| Sleep, REM | 1 | 2023 | 593 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2023 | 804 | 0.040 |
Why?
|
| Carbon Radioisotopes | 1 | 2000 | 544 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 365 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 67 | 0.040 |
Why?
|
| Prognosis | 6 | 2023 | 29948 | 0.040 |
Why?
|
| Disabled Persons | 2 | 2006 | 1208 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2024 | 727 | 0.040 |
Why?
|
| Ubiquitin | 3 | 2010 | 841 | 0.040 |
Why?
|
| Quality Control | 3 | 2014 | 834 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3250 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2021 | 581 | 0.040 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2000 | 174 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1997 | 1550 | 0.040 |
Why?
|
| Probability | 1 | 2004 | 2476 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 332 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 428 | 0.040 |
Why?
|
| Nerve Net | 2 | 2003 | 2307 | 0.040 |
Why?
|
| Models, Biological | 2 | 2005 | 9461 | 0.040 |
Why?
|
| Odontoblasts | 1 | 1997 | 14 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2003 | 459 | 0.040 |
Why?
|
| Adiponectin | 1 | 2024 | 1121 | 0.040 |
Why?
|
| Deoxyglucose | 4 | 2004 | 322 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2001 | 4349 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1998 | 122 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2000 | 534 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 996 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 6002 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2000 | 429 | 0.040 |
Why?
|
| Interphase | 1 | 1998 | 226 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2007 | 1552 | 0.040 |
Why?
|
| Papio | 1 | 1999 | 672 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 2 | 1997 | 471 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2024 | 1065 | 0.040 |
Why?
|
| Axons | 1 | 2005 | 1675 | 0.040 |
Why?
|
| Parasympathomimetics | 1 | 1997 | 28 | 0.040 |
Why?
|
| Point Mutation | 1 | 2002 | 1591 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 7841 | 0.030 |
Why?
|
| Chemokines | 1 | 2021 | 962 | 0.030 |
Why?
|
| Physostigmine | 1 | 1997 | 50 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1133 | 0.030 |
Why?
|
| Hemostatics | 1 | 2000 | 247 | 0.030 |
Why?
|
| DNA Probes | 1 | 1998 | 541 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2010 | 244 | 0.030 |
Why?
|
| Child Abuse | 1 | 2006 | 1090 | 0.030 |
Why?
|
| Child Abuse, Sexual | 1 | 2000 | 398 | 0.030 |
Why?
|
| Gestational Age | 2 | 1996 | 3617 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1998 | 205 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1874 | 0.030 |
Why?
|
| Scopolamine | 1 | 1997 | 92 | 0.030 |
Why?
|
| Registries | 3 | 2019 | 8351 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1997 | 265 | 0.030 |
Why?
|
| Patient Education as Topic | 2 | 2017 | 2334 | 0.030 |
Why?
|
| Radionuclide Imaging | 3 | 2014 | 1986 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2022 | 1194 | 0.030 |
Why?
|
| Anxiety | 2 | 2009 | 4670 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2000 | 527 | 0.030 |
Why?
|
| Proportional Hazards Models | 5 | 2013 | 12534 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 1892 | 0.030 |
Why?
|
| Sensation Disorders | 1 | 1997 | 160 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 3 | 2012 | 2693 | 0.030 |
Why?
|
| Forecasting | 1 | 2005 | 2936 | 0.030 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 135 | 0.030 |
Why?
|
| Differential Threshold | 2 | 2008 | 80 | 0.030 |
Why?
|
| Bipolar Disorder | 3 | 2017 | 5130 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2001 | 588 | 0.030 |
Why?
|
| Young Adult | 7 | 2019 | 59939 | 0.030 |
Why?
|
| Dystonic Disorders | 1 | 2020 | 354 | 0.030 |
Why?
|
| Visual Cortex | 2 | 2012 | 1081 | 0.030 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1996 | 73 | 0.030 |
Why?
|
| United States | 10 | 2017 | 72951 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2001 | 796 | 0.030 |
Why?
|
| Disclosure | 1 | 2021 | 755 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2002 | 848 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2016 | 14471 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 992 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2001 | 1437 | 0.030 |
Why?
|
| Prednisone | 1 | 2000 | 1566 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 1997 | 609 | 0.030 |
Why?
|
| Reaction Time | 2 | 2015 | 2085 | 0.030 |
Why?
|
| Verbal Behavior | 3 | 2001 | 328 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2013 | 497 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2000 | 685 | 0.030 |
Why?
|
| MMPI | 1 | 1994 | 80 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2009 | 12791 | 0.030 |
Why?
|
| Spatial Behavior | 1 | 2015 | 88 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1997 | 628 | 0.030 |
Why?
|
| Hospitalization | 2 | 2013 | 10823 | 0.030 |
Why?
|
| Individuality | 1 | 2016 | 303 | 0.030 |
Why?
|
| X Chromosome | 1 | 1998 | 819 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2000 | 746 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2016 | 196 | 0.030 |
Why?
|
| Cause of Death | 2 | 1995 | 3716 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2021 | 1801 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2013 | 12150 | 0.030 |
Why?
|
| Personality Inventory | 2 | 2007 | 1019 | 0.030 |
Why?
|
| Guanidine | 1 | 2014 | 35 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 1996 | 250 | 0.030 |
Why?
|
| Receptors, Islet Amyloid Polypeptide | 1 | 2013 | 2 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 1995 | 239 | 0.030 |
Why?
|
| Receptors, N-Acetylglucosamine | 1 | 2013 | 11 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5748 | 0.030 |
Why?
|
| Epitopes | 3 | 2012 | 2526 | 0.030 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 11920 | 0.030 |
Why?
|
| Cell Division | 1 | 2001 | 4474 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2017 | 13411 | 0.030 |
Why?
|
| Versicans | 1 | 2013 | 40 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Acetonitriles | 1 | 2014 | 55 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 789 | 0.030 |
Why?
|
| Transducers, Pressure | 1 | 1993 | 51 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 1394 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 104 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2014 | 10100 | 0.030 |
Why?
|
| Plant Lectins | 1 | 2013 | 103 | 0.030 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2013 | 40 | 0.030 |
Why?
|
| Internationality | 1 | 2019 | 1006 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2022 | 3641 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 1997 | 414 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 2746 | 0.030 |
Why?
|
| Avitaminosis | 1 | 1993 | 35 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2013 | 69 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2013 | 110 | 0.030 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2013 | 109 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1182 | 0.030 |
Why?
|
| Factitious Disorders | 1 | 1993 | 39 | 0.030 |
Why?
|
| Homozygote | 2 | 2008 | 1775 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2000 | 738 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2015 | 459 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 136 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3439 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2012 | 238 | 0.030 |
Why?
|
| DNA Repeat Expansion | 1 | 2012 | 74 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2534 | 0.030 |
Why?
|
| Dementia, Vascular | 1 | 2013 | 126 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2017 | 586 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2015 | 540 | 0.020 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 3531 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 474 | 0.020 |
Why?
|
| Proteostasis Deficiencies | 1 | 2012 | 38 | 0.020 |
Why?
|
| Family | 1 | 2003 | 3209 | 0.020 |
Why?
|
| Phenotype | 4 | 2015 | 16724 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2013 | 322 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.020 |
Why?
|
| Sweden | 1 | 2015 | 1382 | 0.020 |
Why?
|
| Space Perception | 1 | 2015 | 468 | 0.020 |
Why?
|
| Anticonvulsants | 2 | 2003 | 1921 | 0.020 |
Why?
|
| Internet | 1 | 2024 | 3113 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1075 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 572 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 499 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1996 | 1966 | 0.020 |
Why?
|
| Calibration | 1 | 2014 | 814 | 0.020 |
Why?
|
| Tissue Banks | 1 | 2012 | 183 | 0.020 |
Why?
|
| Tissue Embedding | 1 | 1991 | 43 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 698 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2015 | 630 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 2000 | 903 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 294 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1186 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 2593 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2011 | 143 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2019 | 3591 | 0.020 |
Why?
|
| Cisplatin | 1 | 1997 | 1655 | 0.020 |
Why?
|
| Social Environment | 1 | 1996 | 1012 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2012 | 504 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2023 | 3618 | 0.020 |
Why?
|
| Microscopy | 1 | 1996 | 902 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2000 | 2158 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 434 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4891 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2000 | 1238 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1895 | 0.020 |
Why?
|
| Movement | 1 | 1997 | 1468 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1171 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1996 | 951 | 0.020 |
Why?
|
| Psychotic Disorders | 2 | 2017 | 3276 | 0.020 |
Why?
|
| Immunoassay | 1 | 2014 | 742 | 0.020 |
Why?
|
| Species Specificity | 2 | 2008 | 2413 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2011 | 255 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1562 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2011 | 256 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 697 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 713 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8540 | 0.020 |
Why?
|
| Medical Records | 1 | 1995 | 1408 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2741 | 0.020 |
Why?
|
| Apoptosis | 2 | 2003 | 9513 | 0.020 |
Why?
|
| Self Concept | 1 | 2015 | 1040 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2017 | 13050 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10445 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1997 | 8106 | 0.020 |
Why?
|
| Algorithms | 2 | 2023 | 14072 | 0.020 |
Why?
|
| Wakefulness | 1 | 1996 | 1282 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2010 | 212 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2717 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 618 | 0.020 |
Why?
|
| Hypokinesia | 1 | 2008 | 23 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1995 | 1139 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 1263 | 0.020 |
Why?
|
| Informed Consent | 1 | 1995 | 1010 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
| Muscle Rigidity | 1 | 2008 | 41 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1751 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 17608 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 2008 | 185 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 4628 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2000 | 2254 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 1211 | 0.020 |
Why?
|
| Seizures | 1 | 2001 | 2996 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1081 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 5789 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2013 | 1160 | 0.020 |
Why?
|
| Patient Selection | 2 | 2001 | 4252 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 626 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2010 | 913 | 0.020 |
Why?
|
| Resilience, Psychological | 1 | 2015 | 808 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1540 | 0.020 |
Why?
|
| Drosophila | 1 | 2015 | 1508 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1751 | 0.020 |
Why?
|
| Violence | 1 | 1993 | 931 | 0.020 |
Why?
|
| Tremor | 1 | 2008 | 196 | 0.020 |
Why?
|
| Neurotic Disorders | 1 | 2007 | 76 | 0.020 |
Why?
|
| Hydrogen Sulfide | 1 | 2008 | 148 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1993 | 1155 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 4539 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2008 | 340 | 0.020 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2006 | 108 | 0.020 |
Why?
|
| Child | 8 | 2006 | 80668 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2002 | 4562 | 0.020 |
Why?
|
| Smoking | 2 | 2001 | 9077 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1997 | 1474 | 0.020 |
Why?
|
| National Health Programs | 1 | 2010 | 444 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7438 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1991 | 1055 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8891 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2008 | 390 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2012 | 3450 | 0.020 |
Why?
|
| Patients | 1 | 2013 | 908 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 465 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 612 | 0.020 |
Why?
|
| Sex Characteristics | 3 | 2007 | 2645 | 0.020 |
Why?
|
| Antigens | 1 | 1991 | 1441 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 4780 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2017 | 24295 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 832 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 2902 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2011 | 708 | 0.020 |
Why?
|
| Prescription Drugs | 1 | 2013 | 634 | 0.020 |
Why?
|
| Self Report | 1 | 2017 | 3771 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 3073 | 0.020 |
Why?
|
| Weight Loss | 1 | 2017 | 2712 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2885 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1673 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2008 | 416 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2006 | 4114 | 0.020 |
Why?
|
| Haloperidol | 1 | 2006 | 394 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1491 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 9101 | 0.010 |
Why?
|
| Hemodynamics | 3 | 1999 | 4188 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2013 | 1838 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 1991 | 741 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2006 | 781 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2008 | 792 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 451 | 0.010 |
Why?
|
| Interleukin-17 | 1 | 2010 | 923 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1991 | 1110 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2006 | 646 | 0.010 |
Why?
|
| Pentanols | 1 | 2003 | 4 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 2006 | 276 | 0.010 |
Why?
|
| Psychology | 1 | 2006 | 353 | 0.010 |
Why?
|
| Motor Neuron Disease | 1 | 2004 | 98 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 2815 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1756 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 2003 | 142 | 0.010 |
Why?
|
| Social Isolation | 1 | 2007 | 366 | 0.010 |
Why?
|
| Introns | 1 | 2006 | 966 | 0.010 |
Why?
|
| Psychotherapy | 1 | 1993 | 1648 | 0.010 |
Why?
|
| Social Adjustment | 1 | 2006 | 634 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2855 | 0.010 |
Why?
|
| Length of Stay | 1 | 2017 | 6490 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 1276 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4055 | 0.010 |
Why?
|
| Clozapine | 1 | 2006 | 509 | 0.010 |
Why?
|
| Workload | 2 | 2000 | 849 | 0.010 |
Why?
|
| Signal Detection, Psychological | 1 | 2003 | 83 | 0.010 |
Why?
|
| Ethylnitrosourea | 1 | 2002 | 50 | 0.010 |
Why?
|
| Qc-SNARE Proteins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Qb-SNARE Proteins | 1 | 2002 | 34 | 0.010 |
Why?
|
| Binding Sites | 1 | 2011 | 6012 | 0.010 |
Why?
|
| Visual Pathways | 1 | 2007 | 554 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 677 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 17088 | 0.010 |
Why?
|
| Amobarbital | 1 | 2002 | 43 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11218 | 0.010 |
Why?
|
| RNA | 1 | 2012 | 2715 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2008 | 846 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 1 | 2003 | 318 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2013 | 2978 | 0.010 |
Why?
|
| Phosphoproteins | 2 | 2002 | 2448 | 0.010 |
Why?
|
| Muscle Strength | 1 | 2006 | 639 | 0.010 |
Why?
|
| HLA-DR4 Antigen | 1 | 2001 | 22 | 0.010 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2001 | 10 | 0.010 |
Why?
|
| Catecholamines | 1 | 1982 | 388 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9525 | 0.010 |
Why?
|
| Leg | 1 | 2006 | 1087 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 772 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 2678 | 0.010 |
Why?
|
| Causality | 1 | 2007 | 1252 | 0.010 |
Why?
|
| Mental Health | 1 | 2015 | 3270 | 0.010 |
Why?
|
| Institutionalization | 1 | 2001 | 108 | 0.010 |
Why?
|
| Language Tests | 1 | 2001 | 191 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2011 | 2903 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2888 | 0.010 |
Why?
|
| gamma-Synuclein | 1 | 1999 | 9 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5454 | 0.010 |
Why?
|
| Critical Care | 1 | 2013 | 2714 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2010 | 1949 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10745 | 0.010 |
Why?
|
| Locomotion | 1 | 2002 | 388 | 0.010 |
Why?
|
| Parenting | 1 | 2006 | 708 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2006 | 2341 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2001 | 42577 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1838 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6359 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2008 | 2115 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1791 | 0.010 |
Why?
|
| Europe | 1 | 2006 | 3430 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1993 | 6408 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 1994 | 3724 | 0.010 |
Why?
|
| Nose | 1 | 2003 | 522 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9320 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2006 | 1827 | 0.010 |
Why?
|
| Melanoma | 1 | 2017 | 5700 | 0.010 |
Why?
|
| Teaching | 1 | 2006 | 1171 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1998 | 164 | 0.010 |
Why?
|
| Metaphase | 1 | 1998 | 143 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4619 | 0.010 |
Why?
|
| CHO Cells | 1 | 2000 | 1376 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1998 | 198 | 0.010 |
Why?
|
| Xenon Radioisotopes | 1 | 1997 | 31 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1997 | 80 | 0.010 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2003 | 783 | 0.010 |
Why?
|
| Fear | 1 | 2006 | 1496 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1999 | 551 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1994 | 4421 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2590 | 0.010 |
Why?
|
| Neostigmine | 1 | 1997 | 68 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2002 | 2342 | 0.010 |
Why?
|
| Dental Pulp | 1 | 1997 | 80 | 0.010 |
Why?
|
| Cricetinae | 1 | 2000 | 2416 | 0.010 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1997 | 85 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1997 | 365 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 2921 | 0.010 |
Why?
|
| Thrombosis | 1 | 1991 | 2953 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2010 | 3242 | 0.010 |
Why?
|
| Incisor | 1 | 1997 | 170 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6512 | 0.010 |
Why?
|
| Spiperone | 1 | 1996 | 31 | 0.010 |
Why?
|
| Receptors, Dopamine D3 | 1 | 1997 | 106 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1997 | 156 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1999 | 1001 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 2000 | 992 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 1206 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 1997 | 279 | 0.010 |
Why?
|
| Child Behavior Disorders | 1 | 2001 | 812 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5923 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1141 | 0.010 |
Why?
|
| Headache | 1 | 2003 | 1260 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2006 | 2077 | 0.010 |
Why?
|
| Hysteria | 1 | 1994 | 20 | 0.010 |
Why?
|
| Prosencephalon | 1 | 1997 | 305 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 2603 | 0.010 |
Why?
|
| Neostriatum | 1 | 1996 | 231 | 0.010 |
Why?
|
| Maxilla | 1 | 1997 | 486 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1996 | 380 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 1997 | 346 | 0.010 |
Why?
|
| Obesity | 1 | 2017 | 13090 | 0.010 |
Why?
|
| Laboratories | 1 | 1998 | 463 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2002 | 1193 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 13643 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3796 | 0.010 |
Why?
|
| Colorado | 1 | 1994 | 167 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 13476 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 946 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 1030 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4853 | 0.010 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1994 | 98 | 0.010 |
Why?
|
| Magnetics | 1 | 1996 | 586 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1995 | 376 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12825 | 0.010 |
Why?
|
| Evoked Potentials, Motor | 1 | 1996 | 463 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1756 | 0.010 |
Why?
|
| Amygdala | 1 | 2000 | 1375 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2001 | 2253 | 0.010 |
Why?
|
| Parents | 1 | 2006 | 3593 | 0.010 |
Why?
|
| Neurofibrils | 1 | 1991 | 75 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 1927 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 9602 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 6066 | 0.010 |
Why?
|
| Homeostasis | 1 | 2002 | 3342 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1997 | 1218 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1974 | 436 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1998 | 2605 | 0.010 |
Why?
|
| Endocarditis | 1 | 1974 | 352 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2000 | 2192 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1997 | 2931 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2000 | 2926 | 0.010 |
Why?
|
| Brain Stem | 1 | 1995 | 858 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 6104 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 1995 | 1118 | 0.000 |
Why?
|
| Radiography | 1 | 1999 | 6968 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 9404 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 2000 | 4559 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5503 | 0.000 |
Why?
|
| Motivation | 1 | 1994 | 2020 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1982 | 395 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1982 | 382 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1982 | 838 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1982 | 898 | 0.000 |
Why?
|
| Infant | 1 | 2001 | 36461 | 0.000 |
Why?
|
| Epinephrine | 1 | 1982 | 782 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1982 | 1478 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1982 | 1516 | 0.000 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1982 | 1241 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1982 | 896 | 0.000 |
Why?
|
| Streptomycin | 1 | 1974 | 69 | 0.000 |
Why?
|
| Glomerulonephritis | 1 | 1974 | 333 | 0.000 |
Why?
|
| Candidiasis | 1 | 1974 | 372 | 0.000 |
Why?
|
| Candida albicans | 1 | 1974 | 377 | 0.000 |
Why?
|
| Penicillins | 1 | 1974 | 404 | 0.000 |
Why?
|
| Heart Rate | 1 | 1982 | 4207 | 0.000 |
Why?
|
| Escherichia coli Infections | 1 | 1974 | 518 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1974 | 618 | 0.000 |
Why?
|
| Myocardium | 1 | 1982 | 4765 | 0.000 |
Why?
|
| Rabbits | 1 | 1974 | 4752 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1974 | 1396 | 0.000 |
Why?
|